Viatris VTRS
NASDAQ VTRS
$16.49 -0.12 (-0.72%)
As of: Sep 9, 2026 · 2:25 PM EDT

Viatris (VTRS) Work In Process (2019 - 2026)

Viatris (VTRS) posted Work In Process of $474.9 million for Q2 2026, up 11.79% on a QoQ basis from $424.8 million in Q1 2026, and down 10.68% year-over-year from $531.7 million in Q2 2025.

Analysis

Viatris (VTRS) Work In Process (2019 - 2026) Analysis & Trends

Viatris has reported Work In Process for 8 years, with the latest figure at $474.9 million in Q2 2026.

  • On a quarterly basis, Work In Process fell 10.68% year-over-year to $474.9 million in Q2 2026; TTM through Jun 2026 was $474.9 million, a 10.68% decrease from a year earlier, with the FY2025 full-year figure at $491.7 million, down 6.75% from the prior year.
  • Work In Process was $474.9 million for Q2 2026 at Viatris, up from $424.8 million in the prior quarter.
  • The five-year high for Work In Process was $1.1 billion in Q2 2023, with the low at $424.8 million in Q1 2026.
  • Average Work In Process over 5 years is $684.5 million, with a median of $589.3 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Work In Process jumped 57.37% in 2024, then tumbled 55.02% in 2025.
  • Over 5 years, Work In Process stood at $755.4 million in 2022, then retreated by 20.29% to $602.1 million in 2023, then decreased by 12.42% to $527.3 million in 2024, then decreased by 6.75% to $491.7 million in 2025, then dropped by 3.42% to $474.9 million in 2026.
  • The last three Work In Process figures came in at $474.9 million (Q2 2026), $424.8 million (Q1 2026), and $491.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 474.90 Mn
Mar 31, 2026 424.80 Mn
Dec 31, 2025 491.70 Mn
Sep 30, 2025 516.00 Mn
Jun 30, 2025 531.70 Mn
Mar 31, 2025 493.70 Mn
Dec 31, 2024 527.30 Mn
Sep 30, 2024 554.80 Mn
Jun 30, 2024 576.50 Mn
Mar 31, 2024 1.10 Bn
Dec 31, 2023 602.10 Mn
Sep 30, 2023 1.03 Bn
Jun 30, 2023 1.13 Bn
Mar 31, 2023 697.40 Mn
Dec 31, 2022 755.40 Mn
Sep 30, 2022 824.60 Mn
Jun 30, 2022 821.70 Mn
Mar 31, 2022 767.50 Mn
Dec 31, 2021 993.30 Mn
Sep 30, 2021 836.40 Mn